大葉大學圖書館 |

Handbook of isolation and characterization of impurities in pharmaceuticals[electronic resource] /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
杜威分類號:	615/.19
書名/作者:	Handbook of isolation and characterization of impurities in pharmaceuticals/ edited by Satinder Ahuja, Karen Mills Alsante.
其他作者:	Ahuja, Satinder,
出版者:	Amsterdam ; : Academic Press,, 2003.
面頁冊數:	xvi, 414 p. : : ill. ;; 27 cm.
標題:	Drugs - Handbooks, manuals, etc. - Purification
標題:	Drugs - Handbooks, manuals, etc. - Separation
標題:	Pharmaceutical Preparations - Handbooks. - analysis
標題:	Drug Contamination - Handbooks. - prevention & control
標題:	Pharmaceutical Preparations - Handbooks. - standards
標題:	Technology, Pharmaceutical - Handbooks. - methods
標題:	M�edicaments - Guides, manuels, etc. - Purification
標題:	M�edicaments - Guides, manuels, etc. - S�eparation
ISBN:	9780120449828
ISBN:	012044982X
書目註:	Includes bibliographical references and index.
內容註:	OVERVIEW: ISOLATION AND CHARACTERIZATION OF IMPURITIES; -- REVIEW OF REGULATORY GUIDANCE ON IMPURITIES; POLYMORPHIC & SOLVATOMORPHIC IMPURITIES; IMPURITIES IN DRUG PRODUCTS; STRATEGIES FOR INVESTIGATION AND CONTROL OF PROCESS AND DEGRADATION-RELATED IMPURITIES; REFERENCE STANDARDS; SAMPLE SELECTION FOR ANALYTICAL METHOD DEVELOPMENT; SAMPLE PREPARATION METHODS; ISOLATION METHODS I: THIN-LAYER CHROMATOGRAPHY; ISOLATION METHODS II: COLUMN CHROMATOGRAPHY; MASS SPECTRAL CHARACTERIZATION; NMR CHARACTERIZATION OF IMPURITES; HYPHENATED CHARACTERIZATION TECHNIQUES; SOLVING IMPURITY/DEGRADATION PROBLEMS: CASE STUDIES.
摘要、提要註:	The United States Food and Drug Administration (FDA) and other regulatory bodies around the world require that impurities in drug substance and drug product levels recommended by the International Conference on Harmonisation (ICH) be isolated and characterized. Identifying process-related impurities and degradation products also helps us to understand the production of impurities and assists in defining degradation mechanisms. When this process is performed at an early stage, there is ample time to address various aspects of drug development to prevent or control the production of impurities and degradation products well before the regulatory filing and thus assure production of a high-quality drug product. This book, therefore, has been designed to meet the need for a reference text on the complex process of isolation and characterization of process-related (synthesis and formulation) impurities and degradation products to meet critical requlatory requirements. It's objective is to provide guidance on isolating and characterizing impurities of pharmaceuticals such as drug candidates, drug substances, and drug products. The book outlines impurity identification processes and will be a key resource document for impurity analysis, isolation/synthesis, and characterization. - Provides valuable information on isolation and characterization of impurities. - Gives a regulatory perspective on the subject. - Describes various considerations involved in meeting regulatory requirements. - Discusses various sources of impurities and degredation products.
電子資源:	An electronic book accessible through the World Wide Web; click for information

Handbook of isolation and characterization of impurities in pharmaceuticals[electronic resource] /
Handbook of isolation and characterization of impurities in pharmaceuticals[electronic resource] /edited by Satinder Ahuja, Karen Mills Alsante. - 1st ed. - Amsterdam ;Academic Press,2003. - xvi, 414 p. :ill. ;27 cm. - Separation science and technology ;v. 5. - Separation science and technology (San Diego, Calif.) ;v. 4..

Includes bibliographical references and index.

OVERVIEW: ISOLATION AND CHARACTERIZATION OF IMPURITIES; -- REVIEW OF REGULATORY GUIDANCE ON IMPURITIES; POLYMORPHIC & SOLVATOMORPHIC IMPURITIES; IMPURITIES IN DRUG PRODUCTS; STRATEGIES FOR INVESTIGATION AND CONTROL OF PROCESS AND DEGRADATION-RELATED IMPURITIES; REFERENCE STANDARDS; SAMPLE SELECTION FOR ANALYTICAL METHOD DEVELOPMENT; SAMPLE PREPARATION METHODS; ISOLATION METHODS I: THIN-LAYER CHROMATOGRAPHY; ISOLATION METHODS II: COLUMN CHROMATOGRAPHY; MASS SPECTRAL CHARACTERIZATION; NMR CHARACTERIZATION OF IMPURITES; HYPHENATED CHARACTERIZATION TECHNIQUES; SOLVING IMPURITY/DEGRADATION PROBLEMS: CASE STUDIES.

The United States Food and Drug Administration (FDA) and other regulatory bodies around the world require that impurities in drug substance and drug product levels recommended by the International Conference on Harmonisation (ICH) be isolated and characterized. Identifying process-related impurities and degradation products also helps us to understand the production of impurities and assists in defining degradation mechanisms. When this process is performed at an early stage, there is ample time to address various aspects of drug development to prevent or control the production of impurities and degradation products well before the regulatory filing and thus assure production of a high-quality drug product. This book, therefore, has been designed to meet the need for a reference text on the complex process of isolation and characterization of process-related (synthesis and formulation) impurities and degradation products to meet critical requlatory requirements. It's objective is to provide guidance on isolating and characterizing impurities of pharmaceuticals such as drug candidates, drug substances, and drug products. The book outlines impurity identification processes and will be a key resource document for impurity analysis, isolation/synthesis, and characterization. - Provides valuable information on isolation and characterization of impurities. - Gives a regulatory perspective on the subject. - Describes various considerations involved in meeting regulatory requirements. - Discusses various sources of impurities and degredation products.

Electronic reproduction.
Amsterdam :
Elsevier Science & Technology,
2007.

Mode of access: World Wide Web.

ISBN: 9780120449828

Source: 90743:90743Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

431390
Drugs
--Purification--Handbooks, manuals, etc.Index Terms--Genre/Form:

336502
Electronic books.

LC Class. No.: RS404.5 / .H355 2003eb

Dewey Class. No.: 615/.19

National Library of Medicine Call No.: 2004 D-216

Handbook of isolation and characterization of impurities in pharmaceuticals[electronic resource] /
LDR:03841cam 2200385Ia 4500 001 347581
003 OCoLC
005 20110615082929.0
006 m d
007 cr cn|||||||||
008 111130s2003 ne a obf 001 0 eng d
020 $a 9780120449828
020 $a 012044982X
029 1 $a NZ1 $b 12434124
029 1 $a DEBSZ $b 316164119
035 $a (OCoLC)162129555
035 $a ocn162129555
037 $a 90743:90743 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $b eng $c OPELS $d OCLCG $d OPELS $d OCLCQ $d DEBSZ
049 $a TEFA
050 1 4 $a RS404.5 $b .H355 2003eb
060 1 4 $a 2004 D-216
060 1 4 $a QV 25 $b H2364 2003
082 0 4 $a 615/.19 $2 22
245 0 0 $a Handbook of isolation and characterization of impurities in pharmaceuticals $h [electronic resource] / $c edited by Satinder Ahuja, Karen Mills Alsante.
250 $a 1st ed.
260 $a Amsterdam ; $a Boston : $b Academic Press, $c 2003.
300 $a xvi, 414 p. : $b ill. ; $c 27 cm.
490 1 $a Separation science and technology ; $v v. 5
504 $a Includes bibliographical references and index.
505 0 $a OVERVIEW: ISOLATION AND CHARACTERIZATION OF IMPURITIES; -- REVIEW OF REGULATORY GUIDANCE ON IMPURITIES; POLYMORPHIC & SOLVATOMORPHIC IMPURITIES; IMPURITIES IN DRUG PRODUCTS; STRATEGIES FOR INVESTIGATION AND CONTROL OF PROCESS AND DEGRADATION-RELATED IMPURITIES; REFERENCE STANDARDS; SAMPLE SELECTION FOR ANALYTICAL METHOD DEVELOPMENT; SAMPLE PREPARATION METHODS; ISOLATION METHODS I: THIN-LAYER CHROMATOGRAPHY; ISOLATION METHODS II: COLUMN CHROMATOGRAPHY; MASS SPECTRAL CHARACTERIZATION; NMR CHARACTERIZATION OF IMPURITES; HYPHENATED CHARACTERIZATION TECHNIQUES; SOLVING IMPURITY/DEGRADATION PROBLEMS: CASE STUDIES.
520 $a The United States Food and Drug Administration (FDA) and other regulatory bodies around the world require that impurities in drug substance and drug product levels recommended by the International Conference on Harmonisation (ICH) be isolated and characterized. Identifying process-related impurities and degradation products also helps us to understand the production of impurities and assists in defining degradation mechanisms. When this process is performed at an early stage, there is ample time to address various aspects of drug development to prevent or control the production of impurities and degradation products well before the regulatory filing and thus assure production of a high-quality drug product. This book, therefore, has been designed to meet the need for a reference text on the complex process of isolation and characterization of process-related (synthesis and formulation) impurities and degradation products to meet critical requlatory requirements. It's objective is to provide guidance on isolating and characterizing impurities of pharmaceuticals such as drug candidates, drug substances, and drug products. The book outlines impurity identification processes and will be a key resource document for impurity analysis, isolation/synthesis, and characterization. - Provides valuable information on isolation and characterization of impurities. - Gives a regulatory perspective on the subject. - Describes various considerations involved in meeting regulatory requirements. - Discusses various sources of impurities and degredation products.
533 $a Electronic reproduction. $b Amsterdam : $c Elsevier Science & Technology, $d 2007. $n Mode of access: World Wide Web. $n System requirements: Web browser. $n Title from title screen (viewed on July 25, 2007). $n Access may be restricted to users at subscribing institutions.
650 0 $a Drugs $x Purification $v Handbooks, manuals, etc. $3 431390
650 0 $a Drugs $x Separation $v Handbooks, manuals, etc. $3 431391
650 1 2 $a Pharmaceutical Preparations $x analysis $v Handbooks. $3 431392
650 2 2 $a Drug Contamination $x prevention & control $v Handbooks. $3 431393
650 2 2 $a Pharmaceutical Preparations $x standards $v Handbooks. $3 431394
650 2 2 $a Technology, Pharmaceutical $x methods $v Handbooks. $3 431395
650 6 $a M�edicaments $x Purification $v Guides, manuels, etc. $3 431396
650 6 $a M�edicaments $x S�eparation $v Guides, manuels, etc. $3 431397
655 4 $a Electronic books. $2 local $3 336502
700 1 $a Ahuja, Satinder, $d 1933- $4 edt $3 404741
700 1 $a Alsante, Karen Mills. $4 edt $3 431389
710 2 $a ScienceDirect (Online service) $3 365609
776 1 $c Original $z 012044982X $z 9780120449828 $w (DLC) 2003040309 $w (OCoLC)51437837
830 0 $a Separation science and technology (San Diego, Calif.) ; $v v. 4. $3 431386
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780120449828 $z An electronic book accessible through the World Wide Web; click for information
994 $a C0 $b TEF